Clinical trials for Malaria
31 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT07147400Pfs230D1 + R21 in Matrix-M1 in African School Children and AdultsSerum Institute of India Pvt. Ltd.
- RECRUITINGPhase 2NCT07036159A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 MonthsGlaxoSmithKline · PI: Julien M Nyombayire, MD, MSc
- ACTIVE NOT RECRUITINGPhase 1NCT06735209First-in-Human PfSPZ-LARC2 Vaccination/CHMINational Institute of Allergy and Infectious Diseases (NIAID)
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06549257Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M AdjuvantUniversity of Oxford · PI: Paola Cicconi, PhD
- ACTIVE NOT RECRUITINGN/ANCT06599593Leveraging the Seasonal Malaria Chemoprevention Platform to Address Malaria and MalnutritionUniversity of California, San Francisco · PI: Catherine Oldenburg
- RECRUITINGPhase 4NCT06860178Integrating Malaria Vaccine With Seasonal Malaria Chemoprevention in West AfricaEpicentre
- RECRUITINGPhase 3NCT06923592Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and MadagascarLondon School of Hygiene and Tropical Medicine · PI: Chris Drakeley
- RECRUITINGPhase 3NCT07082205Monoclonal Antibodies in Children With Severe Anaemia or Severe Malaria to Prevent Malaria After Hospital DischargeLiverpool School of Tropical Medicine · PI: Feiko O Ter Kuile, MD, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT06080243Assessment of Safety, Immunogenicity and Efficacy of R21/Matrix-M1 Malaria Vaccine in Healthy WOCBP in MaliUniversity of Oxford · PI: Adrian Hill, MD
- ACTIVE NOT RECRUITINGPhase 1NCT06652737Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina FasoSanaria Inc. · PI: Thomas L Dr. Thomas L. Richie, MD PhD
- ACTIVE NOT RECRUITINGN/ANCT07281443MDA and Targeted Control Against Plasmodium Carriage in the SahelInstitut de Recherche pour le Developpement
- ACTIVE NOT RECRUITINGPhase 3NCT06516042Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, EthiopiaPATH · PI: Adam Bennett, PhD
- RECRUITINGNCT06468319Pregnancy Registry in MaliNational Institute of Allergy and Infectious Diseases (NIAID) · PI: Kassoum Kayentao, MD, MPH, PhD
- RECRUITINGPhase 4NCT04704999Southeast Asia Dose Optimization of TafenoquineUniversity of Oxford · PI: Cindy Chu, MD, PhD
- RECRUITINGPhase 3NCT06578572Seasonal R21 Mass Vaccination for Malaria EliminationLondon School of Hygiene and Tropical Medicine · PI: Umberto D'Alessandro, MD, MSc, PhD
- RECRUITINGNCT06529237Malaria Molecular Surveillance in Mozambique (Phase 2)Centro de Investigacao em Saude de Manhica
- ENROLLING BY INVITATIONNCT06806956Severe Malaria in Remote Areas- Closing the Evidence GapTropical Diseases Research Centre, Zambia
- ACTIVE NOT RECRUITINGN/ANCT06560853Evaluation of a Comprehensive School Health Programme in ZambiaLondon School of Economics and Political Science · PI: Mylene Lagarde, PhD
- ACTIVE NOT RECRUITINGN/ANCT06155448Perennial Malaria Chemoprevention (PMC) Effect StudyMalaria Consortium · PI: James Tibenderana, PhD
- RECRUITINGPHASE1, PHASE2NCT05790889A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.University of Oxford · PI: Angela Minassian
- ACTIVE NOT RECRUITINGNCT05676645Pharmacokinetics of Antimalarials in Breastfeeding Ugandan Mother-infant PairsUniversity of Liverpool
- ACTIVE NOT RECRUITINGPhase 3NCT05426434Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in PregnancyMenzies School of Health Research · PI: Holger Unger, PhD MBChB
- ACTIVE NOT RECRUITINGNCT05149157Trajectories and Mechanisms of Recovery From Malaria: An Observational StudyImperial College London · PI: Aubrey Cunnington, PhD
- ACTIVE NOT RECRUITINGNCT05426187Follow-up of Immunological Pattern and Pregnancy Outcomes in Women Previously Received Placental Malaria VaccineGroupe de Recherche Action en Sante · PI: Alphonse Ouedraogo, MD, PhD
- RECRUITINGNCT05041556Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria VaccineKintampo Health Research Centre, Ghana · PI: Kwaku Poku Asante, PhD
- ACTIVE NOT RECRUITINGNCT04704674Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, LiberiaNational Institute of Allergy and Infectious Diseases (NIAID) · PI: Jennifer C Hume
- ACTIVE NOT RECRUITINGN/ANCT04419766Evaluation of IR3535 as a Spatial Repellent for Malaria Control.Universidade Nova de Lisboa · PI: Henrique Silveira, PhD
- RECRUITINGNCT02471378Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine CandidatesNational Institute of Allergy and Infectious Diseases (NIAID) · PI: Michal Fried, Ph.D.
- RECRUITINGNCT01168271Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, MaliNational Institute of Allergy and Infectious Diseases (NIAID) · PI: Patrick E Duffy, M.D.
- ACTIVE NOT RECRUITINGPhase 3NCT00131235Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm BirthTampere University · PI: Per Ashorn, MD, PhD
- RECRUITINGNCT00001645Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic InfectionNational Institute of Allergy and Infectious Diseases (NIAID) · PI: Thomas B Nutman, M.D.